Morepen Laboratories has received approval from Finance Committee of the Board of Directors to incorporate Wholly Owned Subsidiary of the Company in a Free Zone at Dubai, United Arab Emirates. The objective of incorporating the wholly owned subsidiary is to carry out the sales & marketing of company's products in international market through a Free Zone in Dubai, UAE.
The Finance Committee of the Board of Directors of the Company, at its meeting held on April 28, 2025 has approved the same.
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products.
